It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ethiopia has the greatest burden of Plasmodium vivax in Africa, but little is known about the epidemiological landscape of parasites across the country. We analysed the genomic diversity of 137 P. vivax isolates collected nine Ethiopian districts from 2012 to 2016. Signatures of selection were detected by cross-country comparisons with isolates from Thailand (n = 104) and Indonesia (n = 111), representing regions with low and high chloroquine resistance respectively. 26% (35/137) of Ethiopian infections were polyclonal, and 48.5% (17/35) of these comprised highly related clones (within-host identity-by-descent > 25%), indicating frequent co-transmission and superinfection. Parasite gene flow between districts could not be explained entirely by geographic distance, with economic and cultural factors hypothesised to have an impact on connectivity. Amplification of the duffy binding protein gene (pvdbp1) was prevalent across all districts (16–75%). Cross-population haplotype homozygosity revealed positive selection in a region proximal to the putative chloroquine resistance transporter gene (pvcrt-o). An S25P variant in amino acid transporter 1 (pvaat1), whose homologue has recently been implicated in P. falciparum chloroquine resistance evolution, was prevalent in Ethiopia (96%) but not Thailand or Indonesia (35–53%). The genomic architecture in Ethiopia highlights circulating variants of potential public health concern in an endemic setting with evidence of stable transmission.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Addis Ababa University, Aklilu Lemma Institute of Pathobiology, Addis Ababa, Ethiopia (GRID:grid.7123.7) (ISNI:0000 0001 1250 5688)
2 Exeins Health Initiative, Jakarta, Indonesia (GRID:grid.7123.7)
3 Menzies School of Health Research and Charles Darwin University, Darwin, Australia (GRID:grid.1043.6) (ISNI:0000 0001 2157 559X); Eijkman Institute for Molecular Biology, Jakarta, Indonesia (GRID:grid.418754.b) (ISNI:0000 0004 1795 0993)
4 University Medical Center Utrecht, Laboratory of Experimental Cardiology, Department of Cardiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000 0000 9012 6352)
5 Menzies School of Health Research and Charles Darwin University, Darwin, Australia (GRID:grid.1043.6) (ISNI:0000 0001 2157 559X)
6 Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382)
7 Ethiopian Public Health Institute, Addis Ababa, Ethiopia (GRID:grid.452387.f) (ISNI:0000 0001 0508 7211); Addis Ababa University, School of Public Health, Addis Ababa, Ethiopia (GRID:grid.7123.7) (ISNI:0000 0001 1250 5688)
8 Armauer Hansen Research Unit (AHRI), Addis Ababa, Ethiopia (GRID:grid.418720.8) (ISNI:0000 0000 4319 4715); Addis Ababa University, Addis Ababa, Ethiopia (GRID:grid.7123.7) (ISNI:0000 0001 1250 5688); Millipore Sigma (Bioreliance), Rockville, USA (GRID:grid.7123.7)
9 Armauer Hansen Research Unit (AHRI), Addis Ababa, Ethiopia (GRID:grid.418720.8) (ISNI:0000 0000 4319 4715)
10 Addis Ababa University, Addis Ababa, Ethiopia (GRID:grid.7123.7) (ISNI:0000 0001 1250 5688)
11 Drexel University, Department of Microbiology and Immunology, College of Medicine, Philadelphia, USA (GRID:grid.166341.7) (ISNI:0000 0001 2181 3113)
12 University of Gondar, Gondar, Ethiopia (GRID:grid.59547.3a) (ISNI:0000 0000 8539 4635)
13 Jimma University, Jimma University Clinical Trial Unit, Department of Internal Medicine, Jimma, Ethiopia (GRID:grid.411903.e) (ISNI:0000 0001 2034 9160)
14 Mahidol University, Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mae Sot, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); University of Oxford, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
15 Eijkman Institute for Molecular Biology, Jakarta, Indonesia (GRID:grid.418754.b) (ISNI:0000 0004 1795 0993)
16 University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
17 Menzies School of Health Research and Charles Darwin University, Darwin, Australia (GRID:grid.1043.6) (ISNI:0000 0001 2157 559X); University of Oxford, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Mahidol University, Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)